PROGRAM 17 NOV
A series of interactive key note lectures including technology and product updates to illustrate the global progress in emerging antimicrobials and AMR diagnostics. During the day participants may enroll in the pre-organised 1:1 matchmaking sessions. The closing session is organised by the Dutch Young Innovators of Medicine (YIM) and will focus on improving the antibiotics innovation climate. The symposium will end with joint networking drinks with EADA participants, YIM delegates and members of the Dutch Innovative Medicines Association.
Part I: Lectures and Matchmaking Sessions
Speakers confirmed:
8:30
Coffee/tea – Infomarket
8:55
Welcome and introduction structure of the program
Dr Maarten van Dongen; Director AMR Insights, The Netherlands
Lectures
09:00
Novel anti-infectives with a focus on infection prevention
Dr Daniel Hynes; Destiny Pharma, Brighton, UK
09:15
Supporting innovators to fight drug-resistant infections
Dr Silke Alt, INCATE, Basel, Switzerland
09:30
mfloDx: a Multiplex Diagnostic Platform for Rapid Detection of MDR & pre-XDR-TB
Prof Sven Hoffner; EMPE Diagnostics AB, Sweden
09:45
Making light work of bacterial infections
Dr Cole Sims, Lightox, UK
10:00
Technology with delivery systems for Destroying ALL pathogens everywhere in medical and other applications
Richard Stead, Qures Uneeke, UK
10:15
Short break (5′)
Parallel program: Lectures
10:20
Anti-virulence strategies to sequester toxins in chronic bacterial infections
Dr Chris Jonkergouw, Arivintx, Finland
Parallel program: Matchmaking Sessions
10:20
Matchmaking sessions round 1 (15′)
10:40
Matchmaking sessions round 2 (15′)
11:00
Matchmaking sessions round 3 (15′)
Part II: Lectures and Matchmaking Sessions
Speakers confirmed:
Lectures
11:15
Fast, accurate reagent free bacteria and clinical yeast identification using infrared spectroscopy and artificial intelligence
Marianne Ismail, Microbira Ltd, UK
11:30
Patient-derived fully-human monoclonal antibodies in next-generation vaccine antigen discovery
Dr Fadil Bidmos, Imperial College London, UK
11:45
Solving P. aeruginosa pulmonary infections by OTX003, a dry-powder inhalation formulation that potentiates existing antibiotics to effectively treat lung infections.
Dr Auke van Heel, Omnicin Therapeutics, The Netherlands
12:00
Reveal Minorities – Spotlighting Pathogens in Complex Clinical Samples
Marina Linow, Molzym GmbH, Germany
12:15
Short break (5′)
Matchmaking Program / Buffet lunch / Infomarket
12:20
Matchmaking sessions round 4 (15′)
12:40
Matchmaking sessions round 5 (15′)
13:00
Matchmaking sessions round 6 (15′)
Part III: Lectures and Matchmaking Sessions
Speakers confirmed:
Lectures
13:30
Cold argon plasma – Proven clinical efficacy as a topical antimicrobial
Mary McGovern, Adtec Healthcare Ltd, UK
13:45
Towards biocompatible immobilized antibacterial coatings based on hyperbranched quaternary ammonium compounds
Prof Ton Loontjes, CTO BioPrex Medical, The Netherlands
14:00
Using next generation antimicrobials to disable virulence
Dr Ronan McCarthy, Brunel University London, UK
14:15
The ABX Antibiotic Discovery Accelerator Network – building a roadmap to drive new discovery
Prof Mathew Upton, School of Biomedical Sciences, Plymouth & Dr Jonathan Cox, Aston University, UK
14:30
Knocking out AMR; the Microbiology Society project
Dr Catrin Moore, St George’s University of London, UK
Parallel program: Lectures
14:50
B2B2B: the JPIAMR-funded network to boost the global development of AMR diagnostics
Dr Maarten van Dongen, AMR Insights (AIM 1), Dr John Hays, Erasmus University Medical Center, NL (AIM 2) & Dr Leonid Chindelevitch , Imperial College London, UK (AIM 3)
15:10
Control the source – AMR exists for a reason
Dr Harley Farmer, Newgenne, UK
15:30
Economic evidence is essential when bringing an antibiotic or diagnostic to market
Dr Elisabeth Adams , Managing Director Aquarius Population Health, UK
Parallel program: Matchmaking Sessions
14:50
Matchmaking sessions round 7 (15′)
15:10
Matchmaking sessions round 8 (15′)
15:30
Matchmaking sessions round 9 (15′)
15:45
End matchmaking program / short break before start YIM program & short break
Innovative Antibiotics in a Resistant World
Interactive session Young Innovators of Medicine
Joint plenary program for all delegates EADA 2023 as well as for registered delegates of the Dutch Young Innovators of Medicine (YIM) and the Dutch Society Innovative Medicines (VIG).
Registration YIM & VIG members for free access
Program:
15:30
Venue open to YIM and VIG members who have registered
Informal get together of EADA 2023 participants and YIM and VIG members who have registered
16:00
Welcome and opening by YIM
Pien Klieverik; Sanofi and Joep Meeuwissen; MSD
16:05
Concluding remarks EADA 2023; expectations Panel Discussion
Maarten van Dongen; AMR Insights
16:15
Antibiotics innovation in a rapidly changing environment
Prof Nathaniel Martin, Leiden University, The Netherlands
16:30
Positioning the antibiotics innovation ecosystem in the context of healthcare, societal and sustainability challenges
Panel discussion led by Pien Kleverik and Joep Meeuwissen; Members: Niké Buijze , Access to Medicine Foundation; Clive Mason, LifeArc; Nathaniel Martin, Leiden University
16:50
Wrap up & closure YIM Program
Pien Klieverik; Sanofi and Joep Meeuwissen; MSD
17:00
Networking over drinks and bites
EADA participants – YIM & VIG members
18:00
Closure
Dr Maarten van Dongen